Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma

Source: Molecular Cancer Research - Category: Cancer & Oncology Tags: Correction Source Type: research